öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º·½Ã÷
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º72

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ£¨ÉöÔಡ£©
Ñо¿ÁìÓò£º 1.Ô­·¢ÐÔÉöСÇò¼²²¡µÄÃâÒß·¢²¡»úÖƼ°×ª»¯Ò½Ñ§Ñо¿¡£2.Äò¶¾Ö¢²¢·¢Ö¢·ÀÖΡ¢ÑªÒº¾»»¯¼¼Êõ¼°Í¸Îö... [Õ¹¿ª]


Ñо¿ÁìÓò£º 1.Ô­·¢ÐÔÉöСÇò¼²²¡µÄÃâÒß·¢²¡»úÖƼ°×ª»¯Ò½Ñ§Ñо¿¡£2.Äò¶¾Ö¢²¢·¢Ö¢·ÀÖΡ¢ÑªÒº¾»»¯¼¼Êõ¼°Í¸Îö¿ªÊ¼Ê±»úµÄÁÙ´²Ñо¿¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºfangming0411@126.com


¸öÈ˼òÊö :
·½Ã÷£¬¸±½ÌÊÚ£¬¸±Ö÷ÈÎҽʦ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬ÉöÄÚ¶þ¿Æ¸±Ö÷ÈΡ£ÏÖ´óÁ¬Ò½¿Æ´óѧÄÚ¿ÆѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÔÚ¶Á²©Ê¿Ñо¿Éú¡£¼æÈÎÖйúÒ©Àíѧ»áÉöÔàÒ©ÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áÈ«¹úίԱ¡¢ÁÉÄþʡҽѧ»áÉöÔಡѧ·Ö»áίԱ¼æÃØÊé¡¢ÖйúÒ½´Ù»áѪ¹ÜÍâ¿Æ·Ö»áѪ¹Üͨ·ѧ×éÇàÄêίԱ¡£´ÓÊÂÉöÔಡÁÙ´²¹¤×÷10ÓàÄ꣬Éó¤ÉöСÇò¼²²¡ÈçIgAÉö²¡¡¢ÀÇ´¯ÐÔÉöÑ׵Ȳ¡µÄÕï¶ÏºÍÖÎÁÆ£¬Î£ÖØÖ¢ÉöÔಡµÄѪҺ¾»»¯ÖÎÁƺÍÂýÐÔÉöÔಡһÌ廯ÖÎÁƵÈ£¬ÊìÁ·ÕÆÎÕÉö´©´Ì»î¼ìÊõ¡¢¶¯¾²ÂöÄÚðü³ÉÐÎÊõ¡¢Éî¾²ÂöÖùÜÊõµÈÊÖÊõ¡£Ö÷³ÖÁÉÄþÊ¡½ÌÓýÌü¿ÆÑлù½ð1Ï±àºÅL**£©£¬¹ú¼ÒÎÀÉú¼ÆÉúί2015Ä깫ÒæÐÔÐÐÒµÖØ´óרÏ±àºÅ**£©ºÍÁÉÄþÊ¡¿Æ¼¼¼Æ»®ÏîÄ¿ÖصãÏîÄ¿£¨±àºÅ**£©¸÷1Ï¾ùÅÅÃûµÚ2£©¡£·¢±íѧÊõÂÛÎÄ9ƪ£¬²Î±à½Ì²Ä1²¿£¬×¨Öø3²¿¡£

¿ÆÑй¤×÷ :
ÔÚÑпÎÌ⣺
Ä¿Ç°Ö÷³Ö¿ÎÌâ1Ï²ÎÓë¿ÎÌâ2Ïî¡£
1. ÁÉÄþÊ¡½ÌÓýÌü¿ÆѧÑо¿Ò»°ãÏîÄ¿£ºµ÷½ÚÐÔBϸ°ûÔÚIgAÉö²¡ÃâÒß·¢²¡»úÖÆÖеÄ×÷Óü°¶ÓÁÐÑо¿£¨ÏîÄ¿±àºÅ£ºL**£©£¬ÁÉÄþÊ¡½ÌÓýÌü£¬2015Äê-2018Ä꣬3ÍòÔª£¬Ö÷³Ö¡£ 2. ¹ú¼ÒÎÀÉú¼ÆÉúί2015Äê¶È¹«ÒæÐÔÐÐÒµ¿ÆÑÐרÏӰÏìÄò¶¾Ö¢»¼ÕßÉú´æÖÊÁ¿ºÍÒ½ÁÆ·ÑÓõĹؼüѪҺ¾»»¯¼¼ÊõµÄÆÀ¼Û¼°¹æ·¶Ó¦Óã¨ÏîÄ¿±àºÅ£º**£©£¬¹ú¼ÒÎÀÉú¼ÆÉúί£¬2015Äê-2018Ä꣬524ÍòÔª£¬ÅÅÃûµÚ2¡£ 3. ÁÉÄþÊ¡¿Æ¼¼¼Æ»®ÏîÄ¿ÖصãÏîÄ¿£ºÁÉÄþÊ¡ÃÚÄòϵͳ¼²²¡×ª»¯Ò½Ñ§Ñо¿ÖÐÐĽ¨É衪¡ª»ùÓÚÉúÎïÑù±¾×ÊÔ´¿âºÍ΢Á÷¿ØоƬ¼¼ÊõµÄIgAÉö²¡½øÕ¹¼à²âÓë·À¿Ø¼°ÐÂÐÍ·Ö²ã¶à°ÐµãÖÎÁƲßÂÔµÄÑо¿£¨ÏîÄ¿±àºÅ£º**£©£¬ÁÉÄþÊ¡¿Æ¼¼Ìü£¬2014Äê-2017Ä꣬100ÍòÔª£¬ÅÅÃûµÚ2¡£

·¢±íÎÄÕ£º
1. Hua Xie, Ming Fang(co-author), Hongli Lin, Ping Li, Jilin Chen, Yanling Sun, Zhe Kang.Intermittent High-volume Hemofiltration Promotes Remission in Steroid-resistant Idiopathic Nephrotic Syndrome. Renal Failure, 2015 Jul37(6):966-73.
2. ·½Ã÷£¬ÁÖºéÀö£¬Ð»»ª£¬³Â¼ªÁÖ£¬ËïÑÞÁᣬÁõÅÎÅÎ. ´ÙÏËÈÜÖÎÁƶÔIgAÉö²¡»¼ÕßÉöÔà±£»¤µÄ»Ø¹ËÐÔ¶ÓÁÐÑо¿£¬ÊµÓÃҽѧÔÓÖ¾£¬2014£¬30£¨9£©£º1405-1407.
3. ·½Ã÷£¬Ðìò«£¬Íõ¿Éƽ£¬ÁõÔ½¼á£¬³ÂÊçÄÝ£¬ÁÖºéÀö. IgAÉö²¡ÍâÖÜѪµ¥¸öºËϸ°ûT-bet¡¢GATA-3¡¢ROR-¦ÃtºÍFoxp3 mRNAµÄ±í´ï¼°ÆäÒâÒåÑо¿£¬ÖйúʵÓÃÄÚ¿ÆÔÓÖ¾£¬2014£¬34£¨9£©£º892-895.
4. Xie Hua, Lin Hongli, Wang Nan, Sun Yanling, Kan Yu, Guo Hui, Chen Jilin, Fang Ming. Inhibition of microRNA-30a prevents puromycin aminonucleoside-induced podocytic apoptosis by upregulating the glucocorticoid receptor ¦Á. Mol Med Rep. 2015 Oct12(4):6043-52. doi: 10.3892/mmr.2015.4226. Epub 2015 Aug 14.8
5. Wang Lingyu, Zhu Jingwei, Fang Ming, Zhang Tuaner, Xie Hua, Wang Nan, Shen Nan, Guo Hui, Fu Bo, Lin Hongli. Inhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes. Int J Mol Sci. 2014 Nov 1815(11):21314-30. doi: 10.3390/ijms**.
6. Wang L, Zhang T, Fang M, Shen N, Wang D, Teng J, Fu B, Xie H, Hong Q, Lin H.Podocytes protect glomerular endothelial cells from hypoxic injury via deSUMOylation of HIF-1¦Á signaling. Int J Biochem Cell Biol. 2015 Jan58:17-27. doi: 10.1016/j.biocel.2014.10.030. Epub 2014 Nov 3.
7. Li N, Xie H, Li L, Wang J, Fang M, Yang N, Lin H.Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats.Inflammation. 2014 Aug 37(4):1191-9. doi: 10.1007/s10753-014-9845-x.
8. ·½Ã÷£¬¿µÀÖ£¬³ÂÓ¢½Ü£¬Áõ½¡£¬Âí¾ýÑ࣬ÌÕÑžý. Smoothened¡¢STAT3ºÍMMP-9ÔÚÈýÒõÐÔÈéÏÙ°©Öеıí´ï¼°ÁÙ´²ÒâÒ壬ÖйúÃâÒßѧÔÓÖ¾£¬2014,30£¨6£©£º821-834.
9. ·½Ã÷£¬¿µÀÖ£¬³ÂÓ¢½Ü£¬Áõ½¡£¬ÌÕÑžý. HIF-1¦Á¶ÔÈéÏÙ°©MCF-7ϸ°ûÔöÖ³µÄÓ°Ïì¼°Æä»úÖÆ̽ÌÖ£¬É½¶«Ò½Ò©£¬2013£¬53£¨40£©£º6-8.